• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9549
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Myocardial Infarction (1969); No Consequences Or Impact To Patient (2199); Heart Failure (2206)
Event Date 08/17/2019
Event Type  Death  
Manufacturer Narrative
Device is a combination product.
 
Event Description
(b)(6) clinical study.It was reported that myocardial infarction, heart failure occurred and patient died.In (b)(6) 2019, the subject presented with unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed which revealed the target lesion #1 located in the left main coronary artery (lmca) to mid left anterior descending artery (lad) with 80% stenosis and was 10mm long, with a reference vessel diameter of 3.5 mm.The target lesion #1 was treated with pre-dilatation and placement of a 3.50 mm x 12 mm and 2.75mm x 16 mm promus premier stent.Following post dilation the residual stenosis was 0%.The target lesion #2 was located in the mid lad with 90% stenosis, and was 8 mm long with a reference vessel diameter of 3.50 mm.The target lesion #2 was treated with pre-dilatation and placement of a 2.75 x 16 mm study stent.Following post-dilatation, the residual stenosis was 0%.Ten days after, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2019, 93 days post index procedure, the subject was diagnosed with myocardial infarction which led to the prolongation of existing hospitalization.It was noted the event led to the seriousness criteria of life threatening illness/injury but was not medically treated.Five days later, the subject passed away.Death certificate and autopsy reports are not available for the event at the moment.
 
Manufacturer Narrative
Correction: this device was reported in error.
 
Event Description
Promus premier china registry.It was reported that myocardial infarction, heart failure occurred and patient died.In (b)(6) 2019, the subject presented with unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed which revealed the target lesion #1 located in the left main coronary artery (lmca) to mid left anterior descending artery (lad) with 80% stenosis and was 10mm long, with a reference vessel diameter of 3.5 mm.The target lesion #1 was treated with pre-dilatation and placement of a 3.50 mm x 12 mm and 2.75mm x 16 mm promus premier stents.Following post dilation the residual stenosis was 0%.The target lesion #2 was located in the mid lad with 90% stenosis, and was 8 mm long with a reference vessel diameter of 3.50 mm.The target lesion #2 was treated with pre-dilatation and placement of a 2.75 x 16 mm study stent.Following post-dilatation, the residual stenosis was 0%.Ten days after, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2019, 93 days post index procedure, the subject was diagnosed with myocardial infarction which led to the prolongation of existing hospitalization.It was noted the event led to the seriousness criteria of life threatening illness/injury but was not medically treated.Five days later, the subject passed away.Death certificate and autopsy reports are not available for the event at the moment.It was previously reported that two stents were implanted in the lmca to mid-lad, but now it is reported the target lesion #1 was only located in the lmca and was 10mm long.The lesion was treated with only one stent, the 3.50x12mm promus premier stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9163218
MDR Text Key161490765
Report Number2134265-2019-12113
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9549
Device Catalogue Number9549
Device Lot Number0022911076
Was Device Available for Evaluation? No
Date Manufacturer Received05/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age80 YR
-
-